$1.66
0.000.00%
Pre-Market: 7:05 AM EDT
Comments
Loading...
Autolus Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:AUTL | Benzinga
Autolus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS Estimate
$-0.240
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$10.12M
Analyze the earnings history of Autolus Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AUTL | Autolus Therapeutics | -$0.24 | -$0.24 | — | — | $10.09M | — | — | — | 05/13/2025 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.45 | -$0.24 | -$0.09 | 62.50% | $0.00 | $2.98M | $29.00K | -99.03% | 03/20/2025 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.26 | -$0.21 | -$0.31 | -47.62% | $406.00K | $130.00K | $0.00 | -100.00% | 11/12/2024 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.26 | -$0.19 | -$0.22 | -15.79% | $0.00 | $60.00K | $0.00 | -100.00% | 08/08/2024 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.23 | -$0.05 | -$0.24 | -380.00% | $1.29M | $25.00M | $10.09M | -59.64% | 05/16/2024 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.23 | -$0.25 | -$0.45 | -80.00% | $3.83M | — | $0.00 | — | 03/14/2024 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.47 | -$0.25 | -$0.26 | -4.00% | $2.37M | $450.00K | $406.00K | -9.78% | 11/02/2023 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.46 | -$0.22 | -$0.26 | -18.18% | $0.00 | $140.00K | $0.00 | -100.00% | 08/03/2023 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.41 | -$0.27 | -$0.23 | 14.81% | $166.00K | $350.00K | $1.29M | 269.14% | 05/04/2023 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.51 | -$0.27 | -$0.23 | 14.81% | $180.00K | $3.20M | $3.83M | 19.53% | 03/07/2023 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.47 | — | -$0.47 | — | $236.00K | — | $2.37M | — | 11/03/2022 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.47 | -$0.42 | -$0.46 | -9.52% | $1.65M | — | $0.00 | — | 08/04/2022 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.53 | — | -$0.41 | — | $269.00K | — | $166.00K | — | 05/05/2022 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.83 | -$0.51 | -$0.51 | 0.00% | $404.00K | $250.00K | $180.00K | -28.00% | 03/10/2022 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.72 | -$0.51 | -$0.47 | 7.84% | $680.00K | $250.00K | $236.00K | -5.60% | 11/03/2021 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.62 | -$0.50 | -$0.47 | 6.00% | $293.00K | $190.00K | $1.65M | 765.79% | 08/05/2021 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.60 | -$0.60 | -$0.53 | 11.67% | $338.00K | $340.00K | $269.00K | -20.88% | 05/06/2021 | Get Alert |
| AUTL | Autolus Therapeutics | — | — | -$0.83 | — | $309.00K | $340.00K | $404.00K | 18.82% | 03/04/2021 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.61 | -$0.71 | -$0.72 | -1.41% | $297.00K | $300.00K | $680.00K | 126.67% | 11/05/2020 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.65 | -$0.71 | -$0.62 | 12.68% | $338.00K | $440.00K | $293.00K | -33.41% | 08/06/2020 | Get Alert |
| AUTL | Autolus Therapeutics | -$0.69 | -$0.74 | -$0.60 | 18.92% | $1.96M | $600.00K | $338.00K | -43.67% | 05/07/2020 | Get Alert |
Autolus Therapeutics (AUTL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-20 | $-0.09 | $-0.24 | 62.5 % |
| Q3 | 2024-11-12 | $-0.31 | $-0.21 | -47.6 % |
| Q2 | 2024-08-08 | $-0.22 | $-0.19 | -15.8 % |
| Q1 | 2024-05-16 | $-0.24 | $-0.05 | -380.0 % |
Autolus Therapeutics (AUTL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-20 | $29.00K | $2.98M | -99.0 % |
| Q3 | 2024-11-12 | $0 | $130.00K | -100.0 % |
| Q2 | 2024-08-08 | $0 | $60.00K | -100.0 % |
| Q1 | 2024-05-16 | $10.09M | $25.00M | -59.6 % |
FAQ
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics (AUTL) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on March 20, 2025 for Q4.
What were the latest earnings per share (EPS) for Autolus Therapeutics (NASDAQ:AUTL)?
The Actual EPS was $-0.09, which beat the estimate of $-0.24.
What were Autolus Therapeutics’s (NASDAQ:AUTL) revenues?
The Actual Revenue was $29K, which missed the estimate of $3M.
Browse earnings estimates, EPS, and revenue on all stocks.